A novel subcutaneous counterpulsation device: Acute hemodynamic efficacy during pharmacologically induced hypertension, hypotension, and heart failure

Artificial Organs

Volumn 34, Issue 7, 2010, Pages 537-545

  Bartoli, Carlo R ^a   Wilson, Gregory C ^a   Giridharan, Guruprasad A ^b   Slaughter, Mark S ^a   Sherwood, Leslie C ^a   Spence, Paul A ^c   Prabhu, Sumanth D ^a   Koenig, Steven C ^a,b  

^a University of Louisville School of Medicine   (United States)

^b University of Louisville   (United States)

^c SCR Inc   (United States)

Author keywords

Cardiac surgery; Counterpulsation; Counterpulsation device; Heart failure; Intra aortic balloon pump

Indexed keywords

BALLOONS; CARDIOLOGY; CARDIOVASCULAR SURGERY; HEART; HEMODYNAMICS;

CARDIAC-SURGERY; CONDITION; COUNTERPULSATION; COUNTERPULSATION DEVICE; HAEMODYNAMICS; HEART FAILURE; INTRA-AORTIC BALLOON PUMP; LEFT VENTRICULAR; PATHOPHYSIOLOGICAL;

BLOOD VESSELS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA BALLOON; ARTICLE; CAROTID ARTERY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; COUNTERPULSATION; COUNTERPULSATION DEVICE; DESCENDING AORTA; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE WORK; HEART MUSCLE OXYGEN CONSUMPTION; HEMODYNAMICS; HYPERTENSION; HYPOTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BOVINAE; CHEMICALLY INDUCED; DEVICES; EQUIPMENT DESIGN; EVALUATION STUDY; HUMAN;

ANIMALS; CATTLE; COUNTERPULSATION; EQUIPMENT DESIGN; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPERTENSION; HYPOTENSION;

EID: 77954350611     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01009.x     Document Type: Article

References (30)

1. Entwistle JW 3rd. Short- and long-term mechanical ventricular assistance towards myocardial recovery. Surg Clin North Am 2004 84 : 201 221.
2. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998 339 : 1522 1533.
3. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001 345 : 1435 1443.
4. Birks EJ, Yacoub MH, Banner NR, Khaghani A. The role of bridge to transplantation: should LVAD patients be transplanted? Curr Opin Cardiol 2004 19 : 148 153.
5. Chinn R, Dembitsky W, Eaton L, et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J 2005 51 : 461 470. (Pubitemid 41076784)
6. Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol 2006 97 : 1391 1398.
7. Sherwood JT, Schomisch SJ, Thompson DR, George DT, Cmolik BL. Aortomyoplasty: hemodynamics and comparison to the intraaortic balloon pump. J Surg Res 2003 110 : 315 321.
8. Patel BG, Shah SH, Astra LI, et al. Skeletal muscle ventricle aortic counterpulsation: function during chronic heart failure. Ann Thorac Surg 2002 73 : 588 593.
9. Nanas JN, Nanas SN, Charitos CE, et al. Hemodynamic effects of a counterpulsation device implanted on the ascending aorta in severe cardiogenic shock. ASAIO Trans 1988 34 : 229 234.
10. Zelano JA, Ko W, Lazzaro R, et al. Comparison of an extraaortic counterpulsation device versus intraaortic balloon pumping in severe cardiac failure. ASAIO Trans 1991 37 : M342 4.
11. Terrovitis JV, Charitos CE, Tsolakis EJ, et al. Superior performance of a paraaortic counterpulsation device compared to the intraaortic balloon pump. World J Surg 2003 27 : 1311 1316.
12. Jeevanandam V, Jayakar D, Anderson AS, et al. Circulatory assistance with a permanent implantable IABP: initial human experience. Circulation 2002 106 : I183 8.
13. Legget ME, Peters WS, Milsom FP, et al. Extra-aortic balloon counterpulsation: an intraoperative feasibility study. Circulation 2005 112 : I26 31.
14. Morley D, Litwak K, Ferber P, et al. Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data. J Thorac Cardiovasc Surg 2007 133 : 21 8.
15. Giridharan GA, Pantalos GM, Litwak KN, Spence PA, Koenig SC. Predicted hemodynamic benefits of counterpulsation therapy using a superficial surgical approach. ASAIO J 2006 52 : 39 46.
16. Koenig SC, Pantalos GM, Litwak KN, et al. Hemodynamic and left ventricular pressure-volume responses to counterpulsation in mock circulation and acute large animal models. Conf Proc IEEE Eng Med Biol Soc 2004 5 : 3761 3764.
17. Koenig SC, Spence PA, Pantalos GM, Dowling RD, Litwak KN. Development and early testing of a simple subcutaneous counterpulsation device. ASAIO J 2006 52 : 362 367.
18. Koenig SC, Litwak KN, Giridharan GA, et al. Acute hemodynamic efficacy of a 32-mL subcutaneous counterpulsation device in a calf model of diminished cardiac function. ASAIO J 2008 54 : 578 584.
19. Smalling RW, Cassidy DB, Barrett R, Lachterman B, Felli P, Amirian J. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model. Circulation 1992 85 : 1152 1159.
20. Laschinger JC, Grossi EA, Cunningham JN Jr., et al. Adjunctive left ventricular unloading during myocardial reperfusion plays a major role in minimizing myocardial infarct size. J Thorac Cardiovasc Surg 1985 90 : 80 5.
21. Koenig SC, Woolard C, Drew G, et al. Integrated data acquisition system for medical device testing and physiology research in compliance with good laboratory practices. Biomed Instrum Technol 2004 38 : 229 240.
22. Schroeder MJ, Perreault B, Ewert DL, Koenig SC. HEART: an automated beat-to-beat cardiovascular analysis package using Matlab. Comput Biol Med 2004 34 : 371 388.
23. Mancini D, Burkhoff D. Mechanical device-based methods of managing and treating heart failure. Circulation 2005 112 : 438 448.
24. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006 355 : 1873 1884.
25. Hall JL, Birks EJ, Grindle S, et al. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 2007 28 : 613 627.
26. Cullen ME, Yuen AH, Felkin LE, et al. Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation 2006 114 : I16 20.
27. Kinoshita M, Takano H, Taenaka Y, et al. Cardiac disuse atrophy during LVAD pumping. ASAIO Trans 1988 34 : 208 212.
28. Kinoshita M, Takano H, Takaichi S, Taenaka Y, Nakatani T. Influence of prolonged ventricular assistance on myocardial histopathology in intact heart. Ann Thorac Surg 1996 61 : 640 645.
29. Moulopoulos SD. The limits of counterpulsation. Int J Artif Organs 1993 16 : 803 805.
30. Koenig SC, Giridharan GA, Ewart DL, et al. Human, bovine and porcine systematic vascular input impedances are not equivalent: implications for device testing and xenotransplantation in heart failure. J Heart Lung Transplant 2008 27 : 1340 1347.